The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Teclistamab, a B-cell maturation antigen (BCMA) x CD3 bispecific antibody, in patients with relapsed/refractory multiple myeloma (RRMM): Updated efficacy and safety results from MajesTEC-1.
 
Ajay K. Nooka
Honoraria - Adaptive Biotechnologies; Amgen; BeyondSpring Pharmaceuticals; Bristol-Myers Squibb/Celgene; Genzyme; GlaxoSmithKline; Janssen Oncology; Karyopharm Therapeutics; Oncopeptides; Secura Bio; Takeda
Consulting or Advisory Role - Adaptive Biotechnologies; Amgen; BeyondSpring Pharmaceuticals; Bristol-Myers Squibb; Genzyme; GlaxoSmithKline; Janssen Oncology; Karyopharm Therapeutics; Oncopeptides; Secura Bio; Takeda
Research Funding - Amgen (Inst); Arch Oncology (Inst); Bristol-Myers Squibb/Celgene (Inst); GlaxoSmithKline (Inst); Janssen Oncology (Inst); Takeda (Inst)
Travel, Accommodations, Expenses - GlaxoSmithKline
 
Philippe Moreau
Honoraria - Abbvie; Amgen; Celgene; GlaxoSmithKline; Janssen-Cilag; oncopeptides; Sanofi
Consulting or Advisory Role - Abbvie; Amgen; Celgene; GlaxoSmithKline; Janssen; oncopeptides; Sanofi
 
Saad Zafar Usmani
Consulting or Advisory Role - Abbvie; Amgen; Bristol-Myers Squibb/Celgene; Celgene; Genentech; Gilead Sciences; GlaxoSmithKline; Janssen Oncology; Karyopharm Therapeutics; Merck; Oncopeptides; Seagen; Skyline Diagnostics; Takeda
Speakers' Bureau - Amgen; Bristol-Myers Squibb/Celgene; Janssen Oncology; Sanofi; Takeda
Research Funding - Amgen; Array BioPharma; Bristol-Myers Squibb; Celgene; GlaxoSmithKline; Janssen Oncology; Merck; Pharmacyclics; Sanofi; Seagen; Skyline Diagnostics
 
Alfred L. Garfall
Stock and Other Ownership Interests - Cabaletta Bio
Consulting or Advisory Role - Amgen; GlaxoSmithKline; Janssen Oncology
Research Funding - crispr therapeutics (Inst); Janssen Oncology (Inst); Novartis (Inst); Tmunity Therapeutics, Inc. (Inst)
Patents, Royalties, Other Intellectual Property - Patent in the field of CAR T cell therapy
 
Niels W.C.J. van de Donk
Honoraria - Bristol-Myers Squibb/Celgene
Consulting or Advisory Role - Amgen; Bayer; Bristol-Myers Squibb/Celgene; Janssen; Novartis; Roche; Takeda
Research Funding - Amgen; Cellectis; Janssen
 
Jesús F. San-Miguel
Consulting or Advisory Role - Abbvie (Inst); Amgen (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); GlaxoSmithKline (Inst); Haemalogix (Inst); Janssen (Inst); Karyopharm Therapeutics (Inst); MSD (Inst); Novartis (Inst); Regeneron (Inst); Roche (Inst); Sanofi (Inst); Secura Bio (Inst); Takeda (Inst)
 
Albert Oriol Rocafiguera
Consulting or Advisory Role - Amgen; Celgene; GlaxoSmithKline; Janssen; Sanofi
Speakers' Bureau - Amgen; Celgene
 
Ajai Chari
Consulting or Advisory Role - Abbvie; Amgen; Antengene; Bristol-Myers Squibb/Celgene; Genentech; Genzyme; GlaxoSmithKline; Janssen Oncology; Karyopharm Therapeutics; OncoPeptides; Seagen; Secura Bio; Shattuck Labs; Takeda
Research Funding - Amgen; Celgene; Janssen; Pharmacyclics; Seagen; Takeda
 
Lionel Karlin
Employment - Aguettant (I)
Honoraria - Amgen; Celgene/Bristol-Myers Squibb; GlaxoSmithKline; Janssen; Sanofi; Takeda
Consulting or Advisory Role - Amgen; Celgene/Bristol-Myers Squibb; GlaxoSmithKline; Janssen; Sanofi; Takeda
Travel, Accommodations, Expenses - Amgen; Janssen; Takeda
 
Maria-Victoria Mateos
Honoraria - Abbvie/Genentech; Amgen; Celgene; GlaxoSmithKline; Janssen-Cilag; Sanofi; Takeda
Consulting or Advisory Role - Abbvie; Amgen; Celgene; GlaxoSmithKline; Janssen-Cilag; Pfizer; Regeneron; Roche/Genentech; Takeda
 
Rakesh Popat
Honoraria - Abbvie; Celgene; GlaxoSmithKline; Janssen; Takeda
Consulting or Advisory Role - Abbvie; Celgene; GlaxoSmithKline
Research Funding - GlaxoSmithKline (Inst)
Travel, Accommodations, Expenses - Janssen; Takeda
 
Joaquin Martinez
Consulting or Advisory Role - BMSi; Janssen Oncology; Novartis
Speakers' Bureau - BMSi; Janssen-Cilag; Roche; Roche
Research Funding - Astellas Pharma (Inst); BMS (Inst)
 
Surbhi Sidana
Consulting or Advisory Role - Bristol-Myers Squibb/Celgene; Janssen; Magenta Therapeutics; Oncopeptides; Sanofi
Research Funding - Allogene Therapeutics (Inst); Bristol-Myers Squibb/Celgene (Inst); Janssen (Inst); Magenta Therapeutics (Inst)
 
Danielle Trancucci
Employment - Janssen
Stock and Other Ownership Interests - Janssen
 
Raluca Verona
Employment - Janssen
Stock and Other Ownership Interests - Janssen
 
Suzette Girgis
Employment - Janssen
Stock and Other Ownership Interests - Janssen
Patents, Royalties, Other Intellectual Property - Janssen
 
Clarissa Uhlar
Employment - Johnson & Johnson
Stock and Other Ownership Interests - Johnson & Johnson
 
Tara Stephenson
Employment - Janssen Oncology
Stock and Other Ownership Interests - Janssen Oncology
Travel, Accommodations, Expenses - Janssen Oncology
 
Arnob Banerjee
Employment - Janssen Research & Development
Stock and Other Ownership Interests - Johnson & Johnson/Janssen
 
Amrita Y. Krishnan
Leadership - Sutro Biopharma
Stock and Other Ownership Interests - Bristol-Myers Squibb
Consulting or Advisory Role - Bristol-Myers Squibb; GlaxoSmithKline; Janssen; Pfizer; Regeneron; Sanofi
Speakers' Bureau - Bristol-Myers Squibb; GlaxoSmithKline; Takeda
Research Funding - Janssen